Skip to main content

Table 1 Patient demographics at the time of PDX collection

From: Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Characteristics

Patient (n = 22)

n (%)

Age, median (range)

70 (33, 81)

Sex

 Male

19 (86)

 Female

3 (14)

Smoking status

 Current/former

15 (68)

 Never

7 (32)

Asbestos exposurea

 Yes

14 (63)

 No

5 (23)

 Unknown

3 (14)

Histology

 Epithelioid

15 (68)

 Biphasic

5 (23)

 Sarcomatoid

2 (9)

Stage at diagnosis

 I–IIIA

14 (64)

 IIIB–IV

8 (36)

Pleurectomy decortication

10 (45)

Thoracic radiation

 IMRT

8 (36)

 Definitive

2 (9)

Platinum + pemetrexed +/− VEGF inhibitor PFS (months)

(n = 20)

 Median (range)

7.8 (1.2, 25.2)

  ≤ 6 months

10

  > 6 months

10

Overall survival (months)

 Median (range)

17.4 (6.2, 50.8)

  1. Demographic and clinicopathologic features of the 22 patients from whom the PDX samples were derived. MSK_LX590 and MSK_LX707 had definitive dosed radiation to the pleura in the non-adjuvant setting
  2. PFS progression-free survival, IMRT intensity-modulated radiation therapy
  3. aClassic self-reported occupational asbestos exposures